A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
CARMEL, Ind., April 23, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced the...
GARDNER, Mass., April 18, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced it has received a $720,000 follow on production order from...
SARASOTA, Fla., April 16, 2024 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and...
BOHEMIA, NY / April 16, 2024 / Scientific Industries, Inc. (OTCQB:SCND) ("SI") announced the appointment of Michael Blechman to the Board of Directors of SI effective April 12, 2024. Mr. Blechman filled a Board vacancy and replaces Mr. Marcus Frampton, who recently...
Today, we feature SOBR Safe, a company that designs and markets non-invasive devices, which detect the presence of alcohol in people using proprietary transdermal technology and algorithms. SOBR Safe is listed on the NASDAQ and trades under the symbol SOBR. Leading us...
PONTE VEDRA, Fla., April 11, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to...
Encinitas, California--(April 11, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has received grant funding from the Choroideremia Research Foundation (CRF) in support of validating functional vision assessments for patients with profound blindness. Functional...
PORTLAND, Maine, April 09, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
CARMEL, Ind., April 09, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the...
FDA designation provides potentially seven years of market exclusivity after approval and expanded partnering opportunities for tecarfarin PONTE VEDRA, Fla., April 9, 2024 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing...